Moran E - Search Results

1

A new monoclonal antibody that specifically recognises the MDR-3-encoded gene product.

Larkin A, Moran E, Alexander D, Doherty G, Connolly L, Kennedy SM, Clynes M. Larkin A, et al. Among authors: moran e. Int J Cancer. 1999 Jan 18;80(2):265-71. doi: 10.1002/(sici)1097-0215(19990118)80:2<265::aid-ijc16>3.0.co;2-#. Int J Cancer. 1999. PMID: 9935209

2

Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.

Larkin A, O'Driscoll L, Kennedy S, Purcell R, Moran E, Crown J, Parkinson M, Clynes M. Larkin A, et al. Among authors: moran e. Int J Cancer. 2004 Nov 1;112(2):286-94. doi: 10.1002/ijc.20369. Int J Cancer. 2004. PMID: 15352042

3

Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.

Moran E, Cleary I, Larkin AM, Amhlaoibh RN, Masterson A, Scheper RJ, Izquierdo MA, Center M, O'Sullivan F, Clynes M. Moran E, et al. Eur J Cancer. 1997 Apr;33(4):652-60. doi: 10.1016/s0959-8049(96)00501-1. Eur J Cancer. 1997. PMID: 9274450

4

A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.

Moran E, Larkin A, Doherty G, Kelehan P, Kennedy S, Clynes M. Moran E, et al. J Clin Pathol. 1997 Jun;50(6):465-71. doi: 10.1136/jcp.50.6.465. J Clin Pathol. 1997. PMID: 9378810 Free PMC article.

5

Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.

Larkin A, Moran E, Alexander D, Clynes M. Larkin A, et al. Among authors: moran e. Adv Exp Med Biol. 1999;457:65-70. doi: 10.1007/978-1-4615-4811-9_8. Adv Exp Med Biol. 1999. PMID: 10500781

6

A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3.

Connolly L, Moran E, Larkin A, Scheffer G, Scheper R, Sarkadi B, Kool M, Clynes M. Connolly L, et al. Among authors: moran e. Hybrid Hybridomics. 2001;20(5-6):333-41. doi: 10.1089/15368590152740734. Hybrid Hybridomics. 2001. PMID: 11839251

7

Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.

Larkin A, Moran E, Kennedy SM, Clynes M. Larkin A, et al. Among authors: moran e. J Immunol Methods. 2005 Aug;303(1-2):53-65. doi: 10.1016/j.jim.2005.05.011. J Immunol Methods. 2005. PMID: 16038928

8

Preliminary studies of a monoclonal antibody raised to the over expressed plasma membrane associated glycoprotein of a multidrug resistant cell line.

Moran E, Redmond A, Clynes M. Moran E, et al. Biochem Soc Trans. 1992 Feb;20(1):58S. doi: 10.1042/bst020058s. Biochem Soc Trans. 1992. PMID: 1353037 No abstract available.

9

Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A.

Redmond A, Moran E, Clynes M. Redmond A, et al. Among authors: moran e. Eur J Cancer. 1993;29A(8):1078-81. doi: 10.1016/s0959-8049(05)80291-6. Eur J Cancer. 1993. PMID: 8100138

10

The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.

Cleary I, Doherty G, Moran E, Clynes M. Cleary I, et al. Among authors: moran e. Biochem Pharmacol. 1997 May 15;53(10):1493-502. doi: 10.1016/s0006-2952(97)00003-8. Biochem Pharmacol. 1997. PMID: 9260877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters